Yago Garitaonaindia, Translational Research Fellow at CCIT-DK – National Center for Cancer Immune Therapy of Denmark, shared a post on LinkedIn:
“As ASCO26 wraps up: is it valuable because it answers questions, or because it opens up many more?
Both. But the second one is what really matters.
New questions are what move the field forward. The best data on stage doesn’t close a conversation, it opens a dozen new ones.
And ASCO26 was never only about the sessions. It was the hallway conversations, the projects sketched over coffee, the science we argued about and the friends from every corner I only get to see once a year.
I’m also truly grateful to have taken part in this year’s meeting as an ASCO Featured Voice. Sharing it with all of you made it so much better.
Came in with a lot of questions.
Leaving with far more.
And always with the verg best Marco Donia
And that’s exactly why I’ll be back, like Terminator.”
